Targeting Tumor–Stromal IL6/STAT3 Signaling through IL1 Receptor Inhibition in Pancreatic CancerAustin R. Dosch(University of Miami), Nipun B. Merchant(Sylvester Comprehensive Cancer Center)Molecular Cancer TherapeuticsSeptember 13, 202110.1158/1535-7163.mct-21-0083Cited by 54SaveCiteExport RISWatch citationsRelated PapersCombined MEK and STAT3 Inhibition Uncovers Stromal Plasticity by Enriching for Cancer-Associated Fibroblasts With Mesenchymal Stem Cell-Like Features to Overcome Immunotherapy Resistance in Pancreatic Cancer|Gastroenterology|2022|157Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells|Oncotarget|2016|113